Want to see HK:6078 full AI Analyst Report?
Hygeia Healthcare Holdings Co., Ltd. (6078) Ratios
Hygeia Healthcare Holdings Co., Ltd. Ratios
HK:6078's free cash flow for Q2 2026 was $292.21M. For the 2026 fiscal year, HK:6078's free cash flow was decreased by $-160.16M and operating cash flow was $452.37M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.01 | 1.02 | 1.02 | 1.71 | 2.01 |
| Quick Ratio | 0.92 | 0.90 | 0.91 | 1.56 | 1.89 |
| Cash Ratio | 0.28 | 0.21 | 0.29 | 0.83 | 0.83 |
| Solvency Ratio | 0.12 | 0.18 | 0.20 | 0.26 | 0.24 |
| Operating Cash Flow Ratio | 0.56 | 0.39 | 0.40 | 0.67 | 0.50 |
| Short-Term Operating Cash Flow Coverage | 2.14 | 1.33 | 1.95 | 3.80 | 12.40 |
| Net Current Asset Value | $ -2.18B | $ -2.43B | $ -2.50B | $ -552.41M | $ -488.45M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.26 | 0.25 | 0.18 | 0.18 |
| Debt-to-Equity Ratio | 0.36 | 0.42 | 0.44 | 0.26 | 0.28 |
| Debt-to-Capital Ratio | 0.27 | 0.30 | 0.30 | 0.21 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.23 | 0.25 | 0.27 | 0.18 | 0.21 |
| Financial Leverage Ratio | 1.58 | 1.64 | 1.72 | 1.47 | 1.50 |
| Debt Service Coverage Ratio | 1.60 | 1.40 | 2.11 | 3.28 | 8.77 |
| Interest Coverage Ratio | 5.69 | 11.43 | 20.60 | 19.12 | 25.72 |
| Debt to Market Cap | 0.35 | 0.33 | 0.13 | 0.04 | 0.05 |
| Interest Debt Per Share | 4.07 | 4.55 | 4.38 | 2.15 | 2.03 |
| Net Debt to EBITDA | 2.00 | 2.42 | 1.95 | 0.50 | 0.84 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.53% | 29.35% | 31.55% | 31.83% | 32.16% |
| EBIT Margin | 17.07% | 18.50% | 22.06% | 23.02% | 22.70% |
| EBITDA Margin | 24.65% | 22.47% | 27.22% | 27.18% | 26.94% |
| Operating Profit Margin | 9.81% | 18.47% | 21.81% | 20.87% | 25.65% |
| Pretax Profit Margin | 8.17% | 16.89% | 21.00% | 20.13% | 24.74% |
| Net Profit Margin | 4.10% | 13.46% | 16.75% | 14.92% | 19.07% |
| Continuous Operations Profit Margin | 4.03% | 13.46% | 16.80% | 15.08% | 19.57% |
| Net Income Per EBT | 50.23% | 79.68% | 79.77% | 74.11% | 77.06% |
| EBT Per EBIT | 83.25% | 91.44% | 96.29% | 96.47% | 96.48% |
| Return on Assets (ROA) | 1.54% | 5.47% | 6.36% | 6.58% | 6.60% |
| Return on Equity (ROE) | 2.43% | 8.99% | 10.96% | 9.66% | 9.91% |
| Return on Capital Employed (ROCE) | 4.38% | 8.99% | 10.11% | 10.73% | 10.18% |
| Return on Invested Capital (ROIC) | 2.06% | 6.77% | 7.74% | 7.94% | 8.10% |
| Return on Tangible Assets | 2.34% | 8.56% | 10.06% | 9.81% | 10.25% |
| Earnings Yield | 2.39% | 7.09% | 3.38% | 1.56% | 1.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.33 | 4.96 | 4.61 | 5.23 | 5.09 |
| Payables Turnover | 5.12 | 5.72 | 4.06 | 5.50 | 5.09 |
| Inventory Turnover | 19.78 | 14.55 | 13.42 | 14.16 | 14.65 |
| Fixed Asset Turnover | 0.76 | 0.88 | 0.85 | 1.07 | 0.92 |
| Asset Turnover | 0.38 | 0.41 | 0.38 | 0.44 | 0.35 |
| Working Capital Turnover Ratio | 165.25 | 144.93 | 10.80 | 4.02 | 1.32 |
| Cash Conversion Cycle | 15.55 | 34.83 | 16.49 | 29.21 | 24.94 |
| Days of Sales Outstanding | 68.43 | 73.54 | 79.17 | 69.81 | 71.68 |
| Days of Inventory Outstanding | 18.46 | 25.08 | 27.20 | 25.78 | 24.91 |
| Days of Payables Outstanding | 71.34 | 63.80 | 89.88 | 66.38 | 71.64 |
| Operating Cycle | 86.88 | 98.62 | 106.37 | 95.59 | 96.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.54 | 1.12 | 1.24 | 1.11 | 0.69 |
| Free Cash Flow Per Share | 0.75 | 0.15 | -0.25 | 0.15 | -0.38 |
| Dividend Paid and CapEx Coverage Ratio | 1.96 | 1.15 | 0.76 | 1.16 | 0.58 |
| Capital Expenditure Coverage Ratio | 1.96 | 1.15 | 0.83 | 1.16 | 0.64 |
| Operating Cash Flow Coverage Ratio | 0.39 | 0.25 | 0.29 | 0.53 | 0.35 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.16 | 0.19 | 0.21 | 0.18 |
| Free Cash Flow Yield | 6.76% | 1.09% | -0.78% | 0.30% | -0.96% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 41.32 | 14.10 | 29.62 | 63.97 | 55.64 |
| Price-to-Sales (P/S) Ratio | 1.72 | 1.90 | 4.96 | 9.54 | 10.61 |
| Price-to-Book (P/B) Ratio | 1.02 | 1.27 | 3.24 | 6.18 | 5.51 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.79 | 91.66 | -128.03 | 330.60 | -103.70 |
| Price-to-Operating Cash Flow Ratio | 7.26 | 11.93 | 25.84 | 44.50 | 57.62 |
| Price-to-Earnings Growth (PEG) Ratio | -0.58 | -1.17 | 0.74 | 7.57 | 0.64 |
| Enterprise Value Multiple | 8.97 | 10.87 | 20.17 | 35.62 | 40.22 |
| Enterprise Value | 8.87B | 10.86B | 22.39B | 30.94B | 25.09B |
| EV to EBITDA | 8.97 | 10.87 | 20.17 | 35.62 | 40.22 |
| EV to Sales | 2.21 | 2.44 | 5.49 | 9.68 | 10.83 |
| EV to Free Cash Flow | 19.01 | 117.98 | -141.72 | 335.32 | -105.92 |
| EV to Operating Cash Flow | 9.33 | 15.35 | 28.60 | 45.14 | 58.85 |
| Tangible Book Value Per Share | 5.07 | 4.34 | 3.65 | 4.14 | 3.39 |
| Shareholders’ Equity Per Share | 10.95 | 10.56 | 9.86 | 8.00 | 7.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.51 | 0.20 | 0.20 | 0.25 | 0.21 |
| Revenue Per Share | 6.48 | 7.06 | 6.45 | 5.18 | 3.75 |
| Net Income Per Share | 0.27 | 0.95 | 1.08 | 0.77 | 0.71 |
| Tax Burden | 0.50 | 0.80 | 0.80 | 0.74 | 0.77 |
| Interest Burden | 0.48 | 0.91 | 0.95 | 0.87 | 1.09 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.12 | 0.10 | 0.10 | 0.08 | 0.09 |
| Stock-Based Compensation to Revenue | -0.00 | -0.00 | 0.01 | 0.01 | 0.00 |
| Income Quality | 5.88 | 0.94 | 1.15 | 1.44 | 0.97 |
Currency in CNY